Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Bronchial Artery-Pulmonary Artery Fistula With Dual Arterial Feeders Treated Successfully With Staged Embolisation Procedures-A Case Report.
Journal: Respirology case reports
Published: September 21, 2025
Rare cause of massive haemoptysis diagnosed by ultrasonography in the ICU.
Journal: Thorax
Published: August 31, 2022
Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors.
Journal: Future oncology (London, England)
Published: March 31, 2022
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer.
Journal: Immunotherapy
Published: August 04, 2021
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 14, 2021
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.
Journal: The Lancet. Oncology
Published: June 01, 2021
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 18, 2020
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2019
Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Journal: JAMA oncology
Published: January 04, 2019
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
Journal: Journal for immunotherapy of cancer
Published: July 19, 2018
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
Journal: Breast cancer research and treatment
Published: September 29, 2017
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 05, 2017
Last Updated: 09/26/2026